Van Lanschot Kempen NV (AMS:VLK)
Netherlands · Delayed Price · Currency is EUR | Market Cap | 2.30B |
| Revenue (ttm) | 733.80M |
| Net Income (ttm) | 126.29M |
| Shares Out | 42.37M |
| EPS (ttm) | 2.98 |
| PE Ratio | 18.19 |
| Forward PE | 16.81 |
| Dividend | 4.15 (7.56%) |
| Ex-Dividend Date | n/a |
| Volume | 50,766 |
| Average Volume | 39,104 |
| Open | 55.10 |
| Previous Close | 54.90 |
| Day's Range | 53.60 - 55.10 |
| 52-Week Range | 38.00 - 59.80 |
| Beta | 0.85 |
| RSI | 63.93 |
| Earnings Date | Feb 26, 2026 |
About Van Lanschot Kempen NV
Van Lanschot Kempen NV provides various financial services in the Netherlands, Belgium, and internationally. It operates through four segments: Private Clients Netherlands, Private Clients Belgium, Investment Management Clients, and Investment Banking Clients. The company offers private banking services for entrepreneurs, family businesses, high-net-worth individuals, business professionals and executives, foundations and associations, and affluent individuals; and pension funds for institutional clients. It also provides wealth management serv... [Read more]
Financial Performance
In 2024, Van Lanschot Kempen NV's revenue was 726.04 million, an increase of 8.80% compared to the previous year's 667.35 million. Earnings were 131.86 million, an increase of 11.32%.
Financial StatementsNews
A market correction? We're in stage 3 out of 5, strategist says
Are we on track for a market correction? Joost Van Leenders from Van Lanschot Kempen addresses the latest concerns raised by the IMF and the BOE over high AI-related valuations.
IMF and Bank of England warnings of an AI bubble fits a pattern, strategist says
Joost van Leenders, senior investment strategist at Dutch asset manager Van Lanschot Kempen, discusses the prospect of an artificial intelligence bubble, and the potential ramifications for global sto...
Van Lanschot Kempen NV (VLNVF) Q2 2025 Earnings Call Transcript
Van Lanschot Kempen NV 2025 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Van Lanschot Kempen NV in conjunction with their 2025 Q2 earnings call.
Van Lanschot Kempen NV reports 1H results
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (("Pharvaris, NASDAQ: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to add...